Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  McDowell, Susan A ^a   McCall, Eileen ^a   Matter, William F ^a   Estridge, Thomas B ^a   Vlahos, Chris J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Fluorescent plate reader; L type calcium channel; LY 294002

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL L TYPE; CALCIUM ION; NICKEL; PHOSPHATIDYLINOSITOL 3 KINASE; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME MECHANISM; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; HEART VENTRICLE CONTRACTILITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; STEADY STATE;

EID: 0942298233     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00546.2003     Document Type: Article

References (51)

1. Arcaro A, Khanzada UK, Vanhaesebroeck B, Tetley TD, Waterfield MD, and Seckl MJ. Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J 21: 5097-5108, 2002.
2. Arcaro A, Zvelebil MJ, Wallasch C, Ullrich A, Waterfield MD, and Domin J. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol Cell Biol 20: 3817-3830, 2000.
3. 2+ exchange current density in cardiac myocytes from rabbits and guinea pigs during postnatal development. Am J Physiol Heart Circ Physiol 268: H1714-H1722, 1995.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Blair LA, Bence-Hanulec KK, Mehta S, Franke T, Kaplan D, and Marshall J. Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J Neurosci 19: 1940-1951, 1999.
6. 2+ oscillations in cardiac cells. J Cell Biol 152: 717-728, 2001.
7. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
8. Cohen NM and Lederer WJ. Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol 406: 115-146, 1988.
9. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, Latronico MV, Napoli C, Sadoshima J, Croce CM, and Ross J Jr. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99: 12333-12338, 2002.
10. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos A.J, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, and Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: 737-749, 2002.
11. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, and Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res 78: 15-25, 1996.
12. Donges C, Heitmann M, Jungbluth H, Meinertz T, Schmelzle B, and Scholz H. Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium and ouabain. Naunyn Schmiedebergs Arch Pharmacol 301: 87-97, 1977.
13. 2+ exchange current in single guinea-pig ventricular cells. J Physiol 410: 227-249, 1989.
14. Fleckenstein A. History of calcium antagonists. Circ Res 52: I3-I16, 1983.
15. Fleckenstein A and Byon KY. Proceedings: prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides. Naunyn Schmiedebergs Arch Pharmacol 282, Suppl: R220, 1974.
16. Grabner M, Wang Z, Hering S, Striessnig J, and Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron 16: 207-218, 1996.
17. Haddock PS, Artman M, and Coetzee WA. Influence of postnatal changes in action potential duration on Na-Ca exchange in rabbit ventricular myocytes. Pflügers Arch 435: 789-795, 1998.
18. Jo SH, Leblais V, Wang PH, Crow MT, and Xiao RP. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ Res 91: 46-53, 2002.
19. Kamp TJ and Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102, 2000.
20. Kimura J, Miyamae S, and Noma A. Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig. J Physiol 384: 199-222, 1987.
21. Kohlhardt M and Fleckenstein A. Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 298: 267-272, 1977.
22. Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, and Katada T. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 272: 24252-24256, 1997.
23. Lin HC, Duncan JA, Kozasa T, and Gilman AG. Sequestration of the G protein beta gamma subunit complex inhibits receptor-mediated endocytosis. Proc Natl Acad Sci USA 95: 5057-5060, 1998.
24. Lytton J, Westlin M, and Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266: 17067-17071, 1991.
25. 2+ channels. Circ Res 89: 692-699, 2001.
26. Maier U, Babich A, and Nurnberg B. Roles of non-catalytic subunits in Gβγ-induced activation of class I phosphoinositide 3-kinase isoforms β and γ. J Biol Chem 274: 29311-29317, 1999.
27. Masuda H, Sumii K, and Sperelakis N. Long openings of calcium channels in fetal rat ventricular cardiomyocytes. Pflügers Arch 429: 595-597, 1995.
28. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, and Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277: 22896-22901, 2002.
29. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, and Rockman HA. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 276: 18953-18959, 2001.
30. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, and Rockman HA. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158: 563-575, 2002.
31. Naga Prasad SV, Perrino C, and Rockman HA. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Trends Cardiovasc Med 13: 206-212, 2003.
32. Quignard JF, Mironneau J, Carricaburu V, Fournier B, Babich A, Nurnberg B, Mironneau C, and Macrez N. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem 276: 32545-32551, 2001.
33. Rameh LE, Rhee SG, Spokes K, Kazlauskas A, Cantley LC, and Cantley LG. Phosphoinositide 3-kinase regulates phospholipase Cγ-mediated calcium signaling. J Biol Chem 273: 23750-23757, 1998.
34. Sadoshima J and Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423, 1993.
35. Sanchez-Margalet V, Zoratti R, and Sung CK. Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing phosphatidylinositol-3-kinase, guanosine triphosphatase-activating protein (GAP), and p62 GAP-associated protein. Endocrinology 136: 316-321, 1995.
36. Sanguinetti MC and Kass RS. Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent. J Mol Cell Cardiol 16: 667-670, 1984.
37. Scholz H. Inotropic drugs and their mechanisms of action. J Am Coll Cardiol 4: 389-397, 1984.
38. Scholz H. Pharmacological actions of various inotropic agents. Eur Heart J 4, Suppl A: 161-172, 1983.
39. Schuster A, Lacinova L, Klugbauer N, Ito H, Birnbaumer L, and Hofmann F. The 1VS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. EMBO J 15: 2365-2370, 1996.
40. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548, 2000.
41. Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF, Cantley LC, and Izumo S. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22: 2799-2809, 2002.
42. Tang S, Yatani A, Bahinski A, Mori Y, and Schwartz A. Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action. Neuron 11: 1013-1021, 1993.
43. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, and Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602, 2001.
44. 2+ channels via phosphoinositide 3-kinase. FASEB J 13: 685-694, 1999.
45. Vlahos CJ, Matter WF, Hui KY, and Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY-294002). J Biol Chem 269: 5241-5248, 1994.
46. Vlahos CJ, McDowell SA, and Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2: 99-113, 2003.
47. 2+-dependent positive inotropic effects in failing human myocardium. Circ Res 92: 169-176, 2003.
48. Wetzel GT and Klitzner TS. Developmental cardiac electrophysiology recent advances in cellular physiology. Cardiovasc Res 31: E52-E60, 1996.
49. Zaccolo M and Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295: 1711-1715, 2002.
50. Zhang J, Banfic H, Straforini F, Tosi L, Volinia S, and Rittenhouse SE. A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate. J Biol Chem 273: 14081-14084, 1998.
51. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev 49: 1-51, 1997.